Cargando…
Differential expression of angiogenesis markers HSP70, HSP90, VEGF and pERK1/2 in both components of dedifferentiated chondrosarcomas
Dedifferentiated chondrosarcomas (DDCS) are highly malignant bimorphic mesenchymal tumors with poor outcome and limited treatment options. Genes and proteins involved in angiogenesis play an important role in the development of invasion and metastasis. Immunohistochemical stains targeting HSP70, pER...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8167291/ https://www.ncbi.nlm.nih.gov/pubmed/34094840 http://dx.doi.org/10.1016/j.jbo.2021.100370 |
_version_ | 1783701664466731008 |
---|---|
author | Schoedel, Karen Miller, Virginia Osei-Hwedieh, David Watters, Rebecca Duensing, Anette John, Ivy Chandran, Uma Chang, Alexander Soman, Vishal Weiss, Kurt |
author_facet | Schoedel, Karen Miller, Virginia Osei-Hwedieh, David Watters, Rebecca Duensing, Anette John, Ivy Chandran, Uma Chang, Alexander Soman, Vishal Weiss, Kurt |
author_sort | Schoedel, Karen |
collection | PubMed |
description | Dedifferentiated chondrosarcomas (DDCS) are highly malignant bimorphic mesenchymal tumors with poor outcome and limited treatment options. Genes and proteins involved in angiogenesis play an important role in the development of invasion and metastasis. Immunohistochemical stains targeting HSP70, pERK1/2 and VEGFA were applied to a TMA containing 29 DDCS cases representing both tumor components. Higher expression of HSP70 and pERK1/2 was noted in the dedifferentiated component. RNA sequencing performed in 8 paired cases of DDCS comparing well differentiated and dedifferentiated components, showed higher expression of several HSP70 family members and HSP90 in the dedifferentiated component. Furthermore, high mobility group AT-hook 2 (HMAG2) and SET nuclear proto-oncogene demonstrated higher expression in the dedifferentiated component. Thus, the well differentiated and dedifferentiated components of DDCS are different, histologically and transcriptomically. The dedifferentiated component of DDCS shows higher expression of markers that are associated with malignant behavior. Some of these may represent future treatment targets. |
format | Online Article Text |
id | pubmed-8167291 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-81672912021-06-05 Differential expression of angiogenesis markers HSP70, HSP90, VEGF and pERK1/2 in both components of dedifferentiated chondrosarcomas Schoedel, Karen Miller, Virginia Osei-Hwedieh, David Watters, Rebecca Duensing, Anette John, Ivy Chandran, Uma Chang, Alexander Soman, Vishal Weiss, Kurt J Bone Oncol Research Paper Dedifferentiated chondrosarcomas (DDCS) are highly malignant bimorphic mesenchymal tumors with poor outcome and limited treatment options. Genes and proteins involved in angiogenesis play an important role in the development of invasion and metastasis. Immunohistochemical stains targeting HSP70, pERK1/2 and VEGFA were applied to a TMA containing 29 DDCS cases representing both tumor components. Higher expression of HSP70 and pERK1/2 was noted in the dedifferentiated component. RNA sequencing performed in 8 paired cases of DDCS comparing well differentiated and dedifferentiated components, showed higher expression of several HSP70 family members and HSP90 in the dedifferentiated component. Furthermore, high mobility group AT-hook 2 (HMAG2) and SET nuclear proto-oncogene demonstrated higher expression in the dedifferentiated component. Thus, the well differentiated and dedifferentiated components of DDCS are different, histologically and transcriptomically. The dedifferentiated component of DDCS shows higher expression of markers that are associated with malignant behavior. Some of these may represent future treatment targets. Elsevier 2021-05-18 /pmc/articles/PMC8167291/ /pubmed/34094840 http://dx.doi.org/10.1016/j.jbo.2021.100370 Text en © 2021 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Research Paper Schoedel, Karen Miller, Virginia Osei-Hwedieh, David Watters, Rebecca Duensing, Anette John, Ivy Chandran, Uma Chang, Alexander Soman, Vishal Weiss, Kurt Differential expression of angiogenesis markers HSP70, HSP90, VEGF and pERK1/2 in both components of dedifferentiated chondrosarcomas |
title | Differential expression of angiogenesis markers HSP70, HSP90, VEGF and pERK1/2 in both components of dedifferentiated chondrosarcomas |
title_full | Differential expression of angiogenesis markers HSP70, HSP90, VEGF and pERK1/2 in both components of dedifferentiated chondrosarcomas |
title_fullStr | Differential expression of angiogenesis markers HSP70, HSP90, VEGF and pERK1/2 in both components of dedifferentiated chondrosarcomas |
title_full_unstemmed | Differential expression of angiogenesis markers HSP70, HSP90, VEGF and pERK1/2 in both components of dedifferentiated chondrosarcomas |
title_short | Differential expression of angiogenesis markers HSP70, HSP90, VEGF and pERK1/2 in both components of dedifferentiated chondrosarcomas |
title_sort | differential expression of angiogenesis markers hsp70, hsp90, vegf and perk1/2 in both components of dedifferentiated chondrosarcomas |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8167291/ https://www.ncbi.nlm.nih.gov/pubmed/34094840 http://dx.doi.org/10.1016/j.jbo.2021.100370 |
work_keys_str_mv | AT schoedelkaren differentialexpressionofangiogenesismarkershsp70hsp90vegfandperk12inbothcomponentsofdedifferentiatedchondrosarcomas AT millervirginia differentialexpressionofangiogenesismarkershsp70hsp90vegfandperk12inbothcomponentsofdedifferentiatedchondrosarcomas AT oseihwediehdavid differentialexpressionofangiogenesismarkershsp70hsp90vegfandperk12inbothcomponentsofdedifferentiatedchondrosarcomas AT wattersrebecca differentialexpressionofangiogenesismarkershsp70hsp90vegfandperk12inbothcomponentsofdedifferentiatedchondrosarcomas AT duensinganette differentialexpressionofangiogenesismarkershsp70hsp90vegfandperk12inbothcomponentsofdedifferentiatedchondrosarcomas AT johnivy differentialexpressionofangiogenesismarkershsp70hsp90vegfandperk12inbothcomponentsofdedifferentiatedchondrosarcomas AT chandranuma differentialexpressionofangiogenesismarkershsp70hsp90vegfandperk12inbothcomponentsofdedifferentiatedchondrosarcomas AT changalexander differentialexpressionofangiogenesismarkershsp70hsp90vegfandperk12inbothcomponentsofdedifferentiatedchondrosarcomas AT somanvishal differentialexpressionofangiogenesismarkershsp70hsp90vegfandperk12inbothcomponentsofdedifferentiatedchondrosarcomas AT weisskurt differentialexpressionofangiogenesismarkershsp70hsp90vegfandperk12inbothcomponentsofdedifferentiatedchondrosarcomas |